Clinical Trials in New York

Showing 5481-5500 of 17,259 trials

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

NCT04079296

The purpose of this study was to evaluate the safety and tolerability and to determine the recommended phase 2 dose (RP2D) and/or the maximum tolerated dose (MTD) of ASP7517. This study also evaluated the clinical response of ASP7517 as well as other measures of anticancer activity of ASP7517.

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome

Astellas Pharma Global Development, Inc.43 participantsStarted Sep 2019

Duarte, California, United States • Pembroke Pines, Florida, United States • New York, New York, United States +13 more locations

COMPLETEDPhase 2< 1 mile

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

NCT03192176

This study determined the effects of different doses and dosing regimens of ESN364 on the frequency and severity of hot flashes. The treatment was administered for 12 weeks to postmenopausal women, aged 40 to 65, suffering at least 50 moderate to severe hot flashes per week.

MenopauseHot Flashes

Astellas Pharma Global Development, Inc.356 participantsStarted Jul 2017

Anniston, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +48 more locations

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

Find Trials by Condition in New York

Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

SCM Muscle as a Marker for Frailty in Patients Undergoing ENT Surgery

A Study of ZN-c3 in Patients With Ovarian Cancer

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

Pegtibatinase As an Enzyme Therapy for Patients with Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE)

Treatment Patterns Among Patients With Venous Thromboembolism in the United States

First in Human Study of M1069 in Advanced Solid Tumors

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN)

Nurse Suicide: Physiologic Sleep Health Promotion Trial

MIRACLE of LIFE Study

Glyburide Advantage in Malignant Edema and Stroke Pilot

Real-World Evaluation of Eko Algorithms in a Point of Care Setting